AG Assanhou, WY Li, L Zhang, LJ Xue, LY Kong, HB Sun, R Mo, C Zhang*. Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment. Biomaterials. 2015, 73: 284-295. (IF: 8.557)
2015 Reversal of multidrug resistance by.pdf
XF Xu, L Zhang, AG Assanhou, L Wang, YD Zhang, WY Li, LJ Xue, R Mo, C Zhang*. Acid/redox dual-activated liposomes for tumortargeted drug delivery and enhanced therapeutic efficacy. RSC Adv. 2015, 5: 67803-67808. (IF: 3.84)
2015 Acid redox dual activated liposomes.pdf
SY Yin, LL Zhou, JS Lin, LJ Xue*, C Zhang*. Design, synthesis and biological activities of novel oxazolo[4,5-g]quinazolin-2(1H)-one derivatives as EGFR inhibitors. Eur J Med Chem. 2015, 101: 462-475. (IF: 3.447)
2015 Design, synthesis and biological activities of novel oxazolo[4,5-g] quinazolin-2(1H)-one derivatives as EGFR inhibitors.pdf
Q Sun, ZS Kang, LJ Xue, YK Shang, ZG Su, R Mo, QN Ping, C Zhang*. A Collaborative Assembly Strategy for Tumor-Targeted siRNA Delivery. J Am Chem Soc. 2015, 137(18): 6000-6010. (IF: 12.113)
2015 A Collaborative Assembly Strategy for Tumor-Targeted siRNA Delivery.pdf
